[
    [
        {
            "time": "2019-09-01",
            "original_text": "华兰生物：梁平单采血浆站取得单采血浆许可证",
            "features": {
                "keywords": [
                    "华兰生物",
                    "单采血浆站",
                    "许可证"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华兰生物：梁平单采血浆站取得单采血浆许可证",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-09-01",
            "original_text": "继续看好医药核心资产，坚守创新、消费和器械【西南医药|0901周报】",
            "features": {
                "keywords": [
                    "医药核心资产",
                    "创新",
                    "消费",
                    "器械"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "继续看好医药核心资产，坚守创新、消费和器械【西南医药|0901周报】",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-09-01",
            "original_text": "【国元医药】2019H1汇总分析：业绩与行情分化持续，强者恒强 盈利能力下降",
            "features": {
                "keywords": [
                    "国元医药",
                    "2019H1",
                    "业绩分化",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【国元医药】2019H1汇总分析：业绩与行情分化持续，强者恒强 盈利能力下降",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-09-01",
            "original_text": "【医药】江琦、祝嘉琦：医药板块2019H1分析暨9月月报：产业结构调整，子板块分化明显，把握结构性机会-20190901",
            "features": {
                "keywords": [
                    "医药板块",
                    "2019H1",
                    "产业结构调整",
                    "子板块分化",
                    "结构性机会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】江琦、祝嘉琦：医药板块2019H1分析暨9月月报：产业结构调整，子板块分化明显，把握结构性机会-20190901",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]